RegulatoryJun 2, 2026, 04:51 PM
INVO Fertility Receives Nasdaq Delinquency Notice for Late Filings
AI Summary
INVO Fertility, Inc. announced it received a delinquency notice from Nasdaq on May 27, 2026, for non-compliance with timely filing requirements for its 2025 Annual Report on Form 10-K and Q1 2026 Quarterly Report on Form 10-Q. The company has since filed the 10-K on June 2, 2026, and is working to file the 10-Q, attributing delays to complex accounting matters. The notice does not immediately affect the stock's Nasdaq listing, and the company has until June 22, 2026, to submit a compliance plan, with a potential extension until October 13, 2026. Despite the filing issues, INVO highlighted recent positive developments including a $7.5 million financing and the acquisition of Family Beginnings.
Key Highlights
- INVO Fertility received a Nasdaq delinquency notice on May 27, 2026, for late filing of its 2025 Form 10-K and Q1 2026 Form 10-Q.
- The company filed its Annual Report on Form 10-K on June 2, 2026.
- The delay was due to additional time needed to review complex accounting matters, including tax provision, variable interest entities, and derivative accounting.
- INVO Fertility has until June 22, 2026, to submit a compliance plan to Nasdaq.
- If the plan is accepted, the company may be granted up to 180 calendar days, until October 13, 2026, to regain compliance.
- The notice has no immediate effect on the listing of the company's common stock on Nasdaq.
- The company completed a $7.5 million financing in January 2026.
- INVO Fertility acquired Family Beginnings, an Indiana-based fertility clinic.
Price Impact
More from IVF